BOSS Translational Medicine, Ltd.
BOSS is a R&D company focusing on autoimmune disease and lymphoma therapies and vaccination enhancement, utilizing the IL-14 gene.
Boss Translational Medicine, Ltd. performs cutting-edge research for clinical products based on technologies that are proprietary and for which it has unique expertise. It develops new tools for the treatment of cancers and adapts them for the management of defined autoimmune diseases. It plans to also create novel technology to enhance the efficiency of all vaccines. Various companies will be sought to help bring these products to market.